Cargando…
PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis
BACKGROUND: PD-L1 tumor expression has been associated with poor prognosis in a variety of solid tumors, including lung cancer, and represents a validated target for immune checkpoint inhibition in advanced malignances. It remains unknown, however, if PD-L1 can be used to predict survival in early s...
Autores principales: | Tuminello, Stephanie, Sikavi, Daniel, Veluswamy, Rajwanth, Gamarra, Cesar, Lieberman-Cribbin, Wil, Flores, Raja, Taioli, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481631/ https://www.ncbi.nlm.nih.gov/pubmed/32953509 http://dx.doi.org/10.21037/tlcr-19-638 |
Ejemplares similares
-
3363 Prognostic Value of Immune-Related Biomarkers in Resected Non-Small Cell Lung Cancer
por: Veluswamy, Rajwanth R, et al.
Publicado: (2019) -
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2019) -
Disparities in COVID-19 Testing and Positivity in New York City
por: Lieberman-Cribbin, Wil, et al.
Publicado: (2020) -
Male Sex, Severe Obesity, Older Age, and Chronic Kidney Disease Are Associated With COVID-19 Severity and Mortality in New York City
por: Rapp, Joseph L., et al.
Publicado: (2021) -
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
por: Tuminello, Stephanie, et al.
Publicado: (2022)